Advertisement

Medically Unexplained Physical Symptoms

  • Jeffrey L. JacksonEmail author
  • Susan George
  • Sherri Hinchey
Editorial

Physical symptoms are the most common reason patients seek medical attention. Among those presenting with symptoms, up to a third remain unexplained, even after thorough investigation1. Fortunately, most patients with unexplained symptoms improve and prospective studies show that the rate of resolution is similar to patients with explained symptoms2. However, there is a subgroup with persistent unexplained symptoms. There are numerous colorful descriptions of such patients, such as “difficult,” “frustrating” or “heartsink,”3 with heartsink referring to the feeling clinicians have when they see a particular name on their schedule. While many patients have unexplained symptoms, the term “medically unexplained symptoms” has taken on a life of its own. Studies investigating the characteristics of “difficult” patient encounters reveal that both patient and physician characteristics play a role.4These patients have multiple, persistent, unexplained physical symptoms. Their symptoms are...

References

  1. 1.
    Kroenke K, Mangelsdorff AD. Common symptoms in ambulatory care: incidence, evaluation, therapy, and outcome. Am J Med. 1989;86(3):262–6.CrossRefPubMedGoogle Scholar
  2. 2.
    Jackson JL, Passamonti M. The outcomes among patients presenting in primary care with a physical symptom at 5 years. J Gen Intern Med. 2005;20(11):1032–37.CrossRefPubMedGoogle Scholar
  3. 3.
    Jewell D. I do not love thee Mr Fell...techniques for dealing with heartsink patients. BMJ. 1988;297:498–9.PubMedCrossRefGoogle Scholar
  4. 4.
    Jackson JL, Kroenke K. Difficult patient encounters in the ambulatory clinic: clinical predictors and outcomes. Arch Intern Med. 1999;159:1069–75.CrossRefPubMedGoogle Scholar
  5. 5.
    Aaron LA, Buchwald D. A review of the evidence for overlap among unexplained clinical conditions. Ann Intern Med. 2001;134(9):868–81.PubMedGoogle Scholar
  6. 6.
    Petrou M, Harris RE, Foerster BR, et al. Proton MR spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: comparison with healthy controls and correlation with symptom severity. Am J Neuroradiol. 2008;29(5):913–8.CrossRefPubMedGoogle Scholar
  7. 7.
    Diers M, Koeppe C, Yilmaz P, et al. Pain ratings and somatosensory evoked responses to repetitive intramuscular and intracutaneous stimulation in fibromyalgia syndrome. J Clin Neurophysiol. 2008;25(3):153–60.CrossRefPubMedGoogle Scholar
  8. 8.
    Kroenke K, Spitzer RL, deGruy FV 3rd, et al. Multisomatoform disorder. An alternative to undifferentiated somatoform disorder for the somatizing patient in primary care. Arch Gen Psychiatry. 1997;54(4):352–8.PubMedGoogle Scholar
  9. 9.
    Jackson JL, Kroenke K. Prevalance, impact and prognosis of multisomatoform disorder in primary care: a 5-year follow-up study. Psychosom Med. 2008;70(4):430–4.CrossRefPubMedGoogle Scholar
  10. 10.
    Jackson JL, Kroenke K. The effect of unmet expectations among adults presenting with physical symptoms. Ann Intern Med. 2001;134:889–97.PubMedGoogle Scholar
  11. 11.
    Salmon P, Ring A, Humphries GM, Davies JC, Dowrick CF. Primary care consultations about medically unexplained symptoms: how do patients indicate what they want? J Gen Intern Med.Google Scholar
  12. 12.
    Peters S, Rogers A, Salmon P, et al. What do patients choose to tell their doctors? Qualitative analysis of potential barriers to reattributing medically unexplained symptoms. J Gen Intern Med.Google Scholar
  13. 13.
    Leiblum SR, Schnall E, Seehuus M, DeMaria A. To BATHE or not to BATHE: patient satisfaction with visits to their family physician. Fam Med. 2008;40(6):407–11.PubMedGoogle Scholar
  14. 14.
    Smith RC, Lyles JS, Gardiner JC, et al. Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med. 2006;21(7):671–7.CrossRefPubMedGoogle Scholar
  15. 15.
    Tofferi JK, O’Malley PG, Jackson JL. Treatment of fibromyalgia with cyclobenzaprine: A metaanalysis. Arthritis Care Res. 2004;51(1):9–13.CrossRefGoogle Scholar
  16. 16.
    O’Malley PG, Jackson JL, Balden E, Tomkins G, Santoro J, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes. J Fam Practice. 1999;48:980–99.Google Scholar
  17. 17.
    Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med. 2007;69(9):881–8.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2009

Authors and Affiliations

  • Jeffrey L. Jackson
    • 1
    Email author
  • Susan George
    • 2
  • Sherri Hinchey
    • 2
  1. 1.Uniformed Services UniversityBethesdaUSA
  2. 2.Walter Reed Army Medical CenterWashingtonUSA

Personalised recommendations